摘要
人类免疫功能低下易导致肿瘤发生,而免疫监视和免疫逃逸机制为肿瘤免疫生物治疗提供了细胞学基础。从免疫系统中T淋巴细胞角度来看,需要从提高免疫功能、有效识别肿瘤细胞和消除抑制性因素三个方面入手,提高细胞毒性T淋巴细胞攻击肿瘤细胞的作用。本文通过分析临床治疗案例,从上述三个方面对细胞因子和免疫修饰治疗、瘤细胞裂解物接种(瘤苗接种)、T细胞基因修饰回输及结合化疗等多种生物治疗的Ⅰ~Ⅲ期临床应用情况进行了总结。并对消除T细胞抑制的信号通路、靶向肿瘤微环境和肿瘤免疫基因治疗进行了分析,以期对肿瘤生物治疗和免疫治疗提供参考和指导。
Human immunosuppression may cause tumor. The knowledge on immune surveillance and tumor immune escape mechanisms provides the cytological basis for tumor immunotherapy, the biological treatment. Focused on T lymphocytes, there are three strategies to improve the ability of those cytotoxic lymphocytes to attack the tumor ceils : improving the immune function, impro- ving their recognition to cancer cells, and eliminating the inhibitory factors to them. Based on the analysis of the clinical therapy cases, a variety of biological events including cytokine therapy, immune-modified therapy, tumor cell lysates vaccination (tumor vaccine ino- culation), ex vivo of gene-modified T cells, and others combined with chemotherapy or immune factor treatment are summrized. And the schematic applications on the elimination of T suppressor in different signaling pathways, targeting tumor microenvironment and tumor immune gene therapy are reviewed as well, in hope of providing information and guidances to tumor immunotherapy.
出处
《国际药学研究杂志》
CAS
CSCD
2013年第2期127-136,共10页
Journal of International Pharmaceutical Research
基金
国家自然科学基金资助项目(30271546)
关键词
肿瘤
免疫疗法
T淋巴细胞
neoplasms
immunotherapy
T lymphocytes